Research:
Since its founding in 1949, the Society has funded more than $550 million in leukemia, lymphoma and myeloma research. Society-funded research has led to key advances in understanding blood cancer and lifesaving drugs and treatments to fight them. Innovations in cancer treatment over the years have included radiation and chemotherapy, stem cell transplantation and new targeted therapies that kill cancer cells without harming normal ones.
Advocacy:
The Society’s advocacy program promotes increased federal funding of biomedical research and influences healthcare reform issues, including ready access to quality cancer care and insurance coverage of patient-care costs in clinical trials.
Professional Education:
The latest research and treatment advances are shared by the Society’s team of medical professionals through medical synopsis, educational events and printed materials.
Patient Services:
The Leukemia & Lymphoma Society has a network of 68 chapters throughout the United States and Canada conducting life-enhancing patient services, including support groups, peer counseling and patient financial aid. The Society also hosts numerous teleconferences and Webcasts, where medical professionals share the latest treatment and clinical trial findings. The Society’s Information Resource Center (IRC), staffed by social workers, nurses and health educators, provides the most current information on leukemia, lymphoma and myeloma free of charge. Call the IRC at 800.955.4572, or visit the Society’s Web site at www.LLS.org.
Who are we:
The Leukemia & Lymphoma Society is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society’s mission is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and to improve the quality of life of patients and their families. Seventy-two cents of every dollar spent will fund life saving research & patient services.
